This content is restricted.
Brief
"On 15/04/2025, the Italian Medicines Agency (AIFA) issued an update regarding AIFA-Regions working group: shared calculation method for the class economic impact of glyphozines. The discussion focused on the transition of glyphozine medicines from direct distribution to pharmacy distribution, as per the Budget Law 2024, with a constructive comparison leading to the sharing of a calculation method to evaluate the economic impact of this change." The AIFA-Regions working group will continue to discuss data on spending elaborated after the price renegotiation of this class of medicines, expected shortly.
Highlights content goes here...
This content is restricted.
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested